Cottencin O, Thomas P, Vaiva G, Rascle C, Goudemand M
Department of Psychiatry, School of Medicine, Centre Hospitalier Regional et Universitaire, University of Lille 2, France.
Pharmacopsychiatry. 1999 Jan;32(1):38-40. doi: 10.1055/s-2007-979186.
Agitation is one of the diagnostic features of catatonia in the DSM IV classification, but permanent forms of agitated catatonia have occasionally been described. We report the case of a 43-year-old man who had already suffered from undifferentiated schizophrenia for 7 years, and in whom we diagnosed agitated catatonia. While our patient was being treated with a neuroleptic during a second episode of paranoia, a state of agitation was observed which persisted for a further 8 months. During this period, he was treated with several different neuroleptics and benzodiazepines, either alone or in association, without any improvement. No organic cause was found. He was then transferred to our electroconvulsive therapy (ECT) unit, with a diagnosis of schizophrenic agitation resistant to drug therapy. ECT was begun, and he was only given droperidol in case of agitation and alimemazine for insomnia, neither of which had any effect. In view of his persistent agitation without any purpose, echolalia and echopraxia, stereotyped movements with mannerisms and marked mimicking and grimacing, we diagnosed him as having agitated catatonia. After the fourth session of ECT, we decided to stop all treatment and gave him lorazepam at a dose of 12.5 mg daily. Twenty-four hours later, all symptoms of agitation had disappeared. In our opinion, permanent catatonic agitation is not rare. In our case, the neuroleptic treatment maintained and may even have worsened the symptomatology. Lorazepam can be used as a therapeutic test for this type of agitation, especially if it does not respond to neuroleptics. This also allows the patient to be sedated rapidly and effectively, thus preventing him from injuring himself further.
激越在《精神疾病诊断与统计手册》第四版(DSM-IV)分类中是紧张症的诊断特征之一,但偶尔也会描述持续性激越型紧张症。我们报告一例43岁男性患者,他患未分化型精神分裂症已7年,此次被诊断为激越型紧张症。在患者偏执狂发作的第二阶段接受抗精神病药物治疗时,观察到激越状态持续了8个月。在此期间,单独或联合使用了几种不同的抗精神病药物和苯二氮䓬类药物治疗,均无改善。未发现器质性病因。随后他被转至我们的电休克治疗(ECT)科,诊断为药物治疗抵抗的精神分裂症激越。开始进行ECT治疗,仅在激越时给予氟哌利多,失眠时给予异丁嗪,但均无效果。鉴于他持续无目的的激越、模仿言语和模仿动作、刻板动作伴特殊姿势以及明显的模仿和鬼脸,我们诊断他为激越型紧张症。在ECT治疗的第四个疗程后,我们决定停止所有治疗,改为每日给予12.5毫克劳拉西泮。24小时后,所有激越症状均消失。我们认为,持续性紧张症激越并不罕见。在我们的病例中,抗精神病药物治疗维持甚至可能加重了症状。劳拉西泮可用于此类激越的治疗试验,尤其是对抗精神病药物无反应时。这也能使患者迅速有效地镇静,从而防止其进一步自伤。